Getting insurance to cover weight loss medication requires understanding what your specific plan covers, meeting medical criteria, and being prepared to navigate prior authorization or appeals if you’re initially denied. Only about 36% of employer-sponsored plans currently cover GLP-1 medications for weight loss, so the process often involves multiple steps before you get a yes.
Check Whether Your Plan Covers Weight Loss Drugs
Before anything else, look at your plan’s formulary and benefit summary. Many plans contain explicit exclusion clauses for “services and supplies for or related to treatment of obesity or for diet and weight control.” If your plan has this language, claims for weight loss medications will be denied regardless of medical necessity, and no amount of documentation from your doctor will override a blanket exclusion. You can usually find your summary plan description on your insurer’s website or by calling the member services number on your insurance card.
Coverage varies dramatically by plan type. Among employer-sponsored plans, 55% cover GLP-1 drugs for diabetes, but only 36% cover them for weight loss specifically. If your employer’s plan excludes weight loss drugs, your main options are asking your employer’s HR department to advocate for adding coverage during the next plan year, or exploring whether the medication can be prescribed for a covered condition (more on that below).
Medicaid and Medicare Have Different Rules
Medicaid coverage for weight loss medications is optional for states, and only 13 state Medicaid programs covered GLP-1s for obesity treatment as of January 2026. Coverage has been volatile: four states (California, New Hampshire, Pennsylvania, and South Carolina) recently eliminated their obesity coverage. Even in states that do cover these drugs, prior authorization is typically required, which adds time and paperwork.
Medicare has historically been prohibited from covering weight loss medications. That is changing through a temporary program called the Medicare GLP-1 Bridge, which runs from July 2026 through December 2027. To qualify, you’ll need to meet specific criteria based on your BMI and other health conditions:
- BMI of 35 or higher: You qualify with no additional diagnosis required.
- BMI of 30 or higher: You qualify if you also have heart failure with preserved ejection fraction, uncontrolled high blood pressure despite taking two blood pressure medications, or chronic kidney disease stage 3a or above.
- BMI of 27 or higher: You qualify if you also have pre-diabetes, a previous heart attack, previous stroke, or symptomatic peripheral artery disease.
If you’re on Medicare and prescribed Wegovy or Zepbound for a condition already covered under Part D (such as cardiovascular risk reduction with Wegovy, or obstructive sleep apnea with Zepbound), coverage goes through your Part D plan rather than the bridge program.
Meet the Medical Necessity Threshold
Even when your plan does cover weight loss medications, you’ll need to meet medical necessity criteria. The FDA-approved indications for these drugs set the baseline: they’re approved for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 to 29.9) who also have at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes.
Many insurers set a higher bar than the FDA label. Your insurer may not cover these drugs unless you have a documented obesity-related medical problem. A high BMI alone may not be sufficient. This means your doctor’s documentation matters enormously. Make sure your medical records clearly show your BMI, any related conditions, and previous weight loss attempts. If you’ve tried diet and exercise programs or other treatments, those should be in your chart.
Prepare for Step Therapy Requirements
Many insurers use “step therapy,” also called fail-first protocols. This means you must try one or more preferred, lower-cost treatments before the insurer will approve a more expensive medication. For weight loss, this might mean trying an older, less expensive medication first and having your doctor document that it didn’t work or caused intolerable side effects.
For diabetes-related prescriptions, insurers commonly require trying a generic medication like metformin before approving a brand-name GLP-1. The same logic applies to weight loss: your plan may require documented attempts with generic options or lower-cost alternatives before covering Wegovy or Zepbound. Ask your insurer exactly what they require so you and your doctor can check each box efficiently rather than discovering requirements one at a time.
Get Your Doctor to Submit Strong Prior Authorization
Most plans that cover weight loss medications require prior authorization, meaning your doctor must submit a request justifying the prescription before the pharmacy will fill it. The strength of this request often determines whether you’re approved or denied on the first try.
Work with your doctor to include your full weight history, BMI measurements over time, any weight-related conditions and their severity, and documentation of previous weight loss efforts including diet, exercise, and any medications you’ve already tried. If your doctor can tie the medication to a specific covered condition (cardiovascular risk, sleep apnea, or diabetes prevention), that can sometimes open a coverage pathway that pure obesity treatment does not.
Appeal a Denial
If your prior authorization is denied, you have the right to appeal. There are two levels of appeal available under federal law.
An internal appeal asks your insurance company to conduct a full review of its own decision. You and your doctor can submit additional supporting documentation at this stage, including new lab results, letters of medical necessity, or evidence that alternative treatments failed. If your situation is urgent, the insurer must expedite the process.
If the internal appeal is denied, you can request an external review, where an independent third party evaluates the case. At this point, the insurance company no longer has the final say. External reviewers look at whether the denial was consistent with medical evidence and your plan’s own criteria. Having thorough documentation from earlier steps makes a meaningful difference here.
Your insurer is required to tell you the specific reason for any denial, which gives you a roadmap for what to address in your appeal. If the denial is based on missing documentation, that’s a straightforward fix. If it’s based on a plan exclusion, an appeal is unlikely to succeed, and your energy is better spent on other options.
Use Manufacturer Savings Programs
If you have commercial insurance that covers the medication but leaves you with a high copay, manufacturer savings cards can reduce your out-of-pocket cost. Zepbound’s savings program, for example, is available to patients with commercial drug insurance who are prescribed the medication for an FDA-approved use. These programs have monthly and annual limits on how much they’ll cover, and they typically exclude anyone on government insurance (Medicare, Medicaid, Tricare).
Savings cards work alongside your insurance, not as a replacement for it. They cover a portion of your copay or coinsurance after your plan has processed the claim. If your plan denies the medication entirely, a savings card won’t help because there’s no insurance claim for it to supplement.
Consider Alternative Coverage Pathways
If your current plan excludes weight loss drugs, you have a few practical options. During open enrollment, look at other available plans and compare their formularies. Some marketplace plans and employer options cover these medications while others don’t, and this single benefit can be worth switching plans for given that the retail price of these drugs runs over $1,000 per month.
If the medication is being prescribed partly for a condition your plan does cover, your doctor may be able to frame the prior authorization around that condition. Wegovy, for instance, is approved for cardiovascular risk reduction in adults with established heart disease and obesity. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. If either of those applies to you, coverage through that pathway may be more straightforward than seeking approval for weight loss alone.